Cross-Chain Compatibility: Injective Protocol is designed to be cross-chain compatible, allowing users to trade assets from different blockchain networks seamlessly. This interoperability expands the ...

After the pain of 2022, last year was encouraging for the broader crypto community. Bitcoin (BTC), Solana (SOL), and Injective Protocol (INJ) rallied, drawing billions to the industry. Injective ...

Back in December last year Injective Protocol launched the testnet for its DeFi protocols for cross-chain derivatives trading, with backing from giant crypto exchange Binance. It has now raised $10 ...

Injective price is down nearly 5% in the past 24 hours, extending recent losses to $3.40 after bulls ran into resistance at the $4.00 mark. The INJ token also declined amid a broader market downturn ...

Injective Protocol, a decentralized derivatives exchange platform, will soon launch trading in tokenized stocks of major companies like Google. Injective said Monday it would use oracle technology to ...

The developers of Injective Protocol, a “fully” decentralized layer-2 digital assets derivatives exchange protocol powering cross-chain trading and (decentralized finance) DeFi, has released a new ...

The developers of Injective Protocol, a “decentralized” derivatives exchange, have acquired $2.6 million through a seed funding round that was led by Pantera Capital. Injective Protocol has been ...

Injective Protocol, an Ethereum-compatible blockchain used in decentralized finance (DeFi) and derivatives industries, underwent a "CosmWasm mainnet" upgrade in early in July in order to provide ...

Decentralized exchange protocols that allow crypto traders and investors to trade across different blockсhains have been in development for a while. A significant new development now comes with the ...

Decentralized smart contracts platform Injective raised $40 million in a funding round that was led by Jump Crypto, the company said on Wednesday. BH Digital, the crypto and digital asset unit of ...